First Manhattan CO Imv Inc. Transaction History

First Manhattan CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$2.87 - $5.95 $61,992 - $128,520	-21,600 Reduced 24.55%	66,368 $294,000
Q1 2020 May 06, 2020	SELL	$1.4 - $4.92 $31,359 - $110,208	-22,400 Reduced 20.3%	87,968 $153,000
Q4 2019 Feb 13, 2020	SELL	$2.15 - $3.1 $14,835 - $21,390	-6,900 Reduced 5.88%	110,368 $320,000
Q2 2019 Aug 16, 2019	SELL	$2.75 - $4.5 $102,437 - $167,625	-37,250 Reduced 24.11%	117,268 $342,000
Q1 2019 Apr 12, 2019	BUY	$3.6 - $5.84 $239,580 - $388,652	66,550 Added 75.65%	154,518 $620,000
Q3 2018 Oct 15, 2018	BUY	$4.65 - $5.94 $409,051 - $522,529	87,968 New	87,968 $522,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.